1. Use of 18 F-FDG PET-CT imaging to determine internal mammary lymph node location for radiation therapy treatment planning in breast cancer patients
    Tima Davidson et al, 2017, Practical Radiation Oncology CrossRef
  2. Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastases
    Vincent Vinh-Hung et al, 2017, World Journal of Radiology CrossRef
  3. Influence of [18F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
    Sebastian Werner et al, 2023, Diagnostics CrossRef
  4. Is PET/CT Necessary in the Management of Early Breast Cancer?
    Gül Nihal Nursal et al, 2016, Clinical Nuclear Medicine CrossRef
  5. Present and future role of FDG-PET/CT imaging in the management of breast cancer
    Kazuhiro Kitajima et al, 2016, Japanese Journal of Radiology CrossRef
  6. Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer
    Sangwon Han et al, 2021, Clinical Nuclear Medicine CrossRef
  7. Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients
    Laura Evangelista et al, 2017, Nuclear Medicine Communications CrossRef
  8. Prognostic Value of SUVmax of <sup>18</sup>F-FDG PET/CT in Early Stage Breast Cancer with No LN Metastasis
    Ryusuke Murakami et al, 2017, Open Journal of Medical Imaging CrossRef
  9. Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer
    Abdulselam Özdemir et al, 2023, Clinical and Translational Oncology CrossRef
  10. The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
    Kazunori Kubota et al, 2024, Breast Cancer CrossRef
  11. PET/MRI in breast cancer
    W. V. Vogel et al, 2017, Clinical and Translational Imaging CrossRef